OASM CLASS ACTION DEADLINE: Hagens Berman Reminds Investors in Oasmia Pharmaceutical AB (OASM) of Upcoming Lead Plaintiff Deadline

World News: . []

SAN FRANCISCO, Sept. 10, 2019 (GLOBE NEWSWIRE) -- Hagens Berman reminds investors in () of the lead plaintiff deadline in a federal securities class action against the company.

If you invested in Oasmia securities and suffered – one who selects and oversees the attorneys prosecuting the case.

or contact Reed Kathrein, who is leading the firm’s investigation, by calling or emailing

This news caused the price of Oasmia shares to decline.

“We’re focused on investors’ losses and the extent to which Oasmia misled investors about improper related-party transactions,” said Hagens Berman partner Reed Kathrein.

More news and information about Hagens Berman Sobol Shapiro LLP

Published By:

Globe Newswire: 01:08 GMT Wednesday 11th September 2019

Published: .

Search for other references to "oasm" on SPi News


Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
Privacy Policy | Terms and Conditions | Contact Us